相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cytokine and epigenetic regulation of programmed death-ligand 1 in stem cell differentiation and cancer cell plasticity
Ming-Han Kuo et al.
STEM CELLS (2021)
MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells
Thijs S. Stutvoet et al.
JOURNAL OF PATHOLOGY (2019)
Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering
Liam Lawlor et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2019)
Generation and Applications of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
Chengzhu Zhao et al.
STEM CELLS INTERNATIONAL (2018)
Crosstalk between SOX2 and cytokine signaling in endometrial carcinoma
Chang-Jung Lee et al.
SCIENTIFIC REPORTS (2018)
Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance
Pamina Contreras-Kallens et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Non-Smad Signaling Pathways of the TGF-β Family
Ying E. Zhang
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
A targetable HB-EGF-CITED4 axis controls oncogenesis in lung cancer
C-H Hsieh et al.
ONCOGENE (2017)
Epigenetic Switch between SOX2 and SOX9 Regulates Cancer Cell Plasticity
Sheng-Chieh Lin et al.
CANCER RESEARCH (2016)
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
Justin F. Gainor et al.
CLINICAL CANCER RESEARCH (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1)
Masaki Shimoji et al.
LUNG CANCER (2016)
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
Chan-Young Ock et al.
ONCOTARGET (2016)
Impaired ROS Scavenging System in Human Induced Pluripotent Stem Cells Generated from Patients with MERRF Syndrome
Shih-Jie Chou et al.
SCIENTIFIC REPORTS (2016)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials
Jason Madore et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall- cell lung cancer
K. Azuma et al.
ANNALS OF ONCOLOGY (2014)
An Effective Approach to Prevent Immune Rejection of Human ESC-Derived Allografts
Zhili Rong et al.
CELL STEM CELL (2014)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma
Nanae Tomonaga et al.
CLINICAL LUNG CANCER (2013)
Small RNA-mediated regulation of iPS cell generation
Zhonghan Li et al.
EMBO JOURNAL (2011)
Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice
Shinji Kaichi et al.
CARDIOVASCULAR RESEARCH (2010)
Inflammation and Colon Cancer
Janos Terzic et al.
GASTROENTEROLOGY (2010)
Is Cytology Reliable for Epidermal Growth Factor Receptor Gene Evaluation in Non-small Cell Lung Cancer?
Cecilia Bozzetti et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Evidence That SOX2 Overexpression Is Oncogenic in the Lung
Yun Lu et al.
PLOS ONE (2010)
Sox2 Uses Multiple Domains to Associate with Proteins Present in Sox2-Protein Complexes
Jesse L. Cox et al.
PLOS ONE (2010)
Cancer Metastasis Is Accelerated through Immunosuppression during Snail-induced EMT of Cancer Cells
Chie Kudo-Saito et al.
CANCER CELL (2009)
A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog
Justin K. Ichida et al.
CELL STEM CELL (2009)
Tgfβ Signal Inhibition Cooperates in the Induction of iPSCs and Replaces Sox2 and cMyc
Nimet Maherali et al.
CURRENT BIOLOGY (2009)
Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency
Akitsu Hotta et al.
NATURE METHODS (2009)
Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer
Kohei Miyazono
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib
Kazuya Taniguchi et al.
CANCER SCIENCE (2008)
TGF-β:: A master of all T cell trades
Ming O. Li et al.
CELL (2008)
Sox2 is important for two crucial processes in lung development: Branching morphogenesis and epithelial cell differentiation
Cristina Gontan et al.
DEVELOPMENTAL BIOLOGY (2008)
Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells
Helen Fong et al.
STEM CELLS (2008)
PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection
Katsunori Tanaka et al.
JOURNAL OF IMMUNOLOGY (2007)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells
G Anumanthan et al.
BRITISH JOURNAL OF CANCER (2005)
TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
RS Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation
M Krampera et al.
BLOOD (2005)
Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo
T Ito et al.
JOURNAL OF IMMUNOLOGY (2005)
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway
A Augello et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
